MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells

por CAO, MENGRU, SEIKE, MASAHIRO, SOENO, CHIE, MIZUTANI, HIDEAKI, KITAMURA, KAZUHIRO, MINEGISHI, YUJI, NORO, RINTARO, YOSHIMURA, AKINOBU, CAI, LI, GEMMA, AKIHIKO
Publicado 2012

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer

por Matsumoto, Masaru, Seike, Masahiro, Noro, Rintaro, Soeno, Chie, Sugano, Teppei, Takeuchi, Susumu, Miyanaga, Akihiko, Kitamura, Kazuhiro, Kubota, Kaoru, Gemma, Akihiko
Publicado 2015

MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation

por Noro, Rintaro, Seike, Masahiro, Zou, Fenfei, Soeno, Chie, Matsuda, Kuniko, Sugano, Teppei, Nishijima, Nobuhiko, Matsumoto, Masaru, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Yoshimura, Akinobu, Kubota, Kaoru, Gemma, Akihiko
Publicado 2015

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

por Miyanaga, Akihiko, Shimizu, Kumi, Noro, Rintaro, Seike, Masahiro, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Shukuya, Takehito, Yoshimura, Akinobu, Kawamoto, Masashi, Tsuchiya, Shinichi, Hagiwara, Koichi, Soda, Manabu, Takeuchi, Kengo, Yamamoto, Nobuyuki, Mano, Hiroyuki, Ishikawa, Yuichi, Gemma, Akihiko
Publicado 2013